Health related quality of life in patients having schizophrenia negative symptoms – a systematic review

Health related quality of life in patients having schizophrenia negative symptoms – a systematic review

Background: Schizophrenia negative symptoms (SNS) contribute substantially to poor functional outcomes, loss in productivity and poor quality of life. It is unclear which instruments may be used for assessing quality of life in patients with SNS. Objective: The objective of this review was to identi...

Full description

Saved in:

Bibliographic Details
Main Authors:	Chiraz Azaiez, Aurélie Millier, Christophe Lançon, Emilie Clay, Pascal Auquier, Pierre-Michel Llorca, Mondher Toumi
Format:	Article
Language:	English
Published:	MDPI AG 2018-01-01
Series:	Journal of Market Access & Health Policy
Subjects:	Health related quality of life negative symptoms validation instruments psychometric properties schizophrenia
Online Access:	http://dx.doi.org/10.1080/20016689.2018.1517573
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Psychometric properties and diagnostic criteria of Scale for the assessment of negative symptoms (SANS) in schizophrenia
by: M. V. Assanovich, et al.
Published: (2021-04-01)

Psychometric properties and diagnostic criteria of Negative Symptoms Assessment-5 (NSA-5) in schizophrenia
by: M. V. Assanovich
Published: (2020-04-01)

Evaluation of Typical Antipsychotic Augmentation with Citalopram in Reduction of Negative Symptoms in Inpatient Schizophrenia in Ahvaz Golestan Hospital
by: Masome Nazari Nasab, et al.
Published: (2012-09-01)

Healthcare resource use in schizophrenia, EuroSC findings
by: A. Millier, et al.
Published: (2017-01-01)

Systematic review of pharmacoeconomic models for schizophrenia
by: Junwen Zhou, et al.
Published: (2018-01-01)

Effect of cariprazine on attention and quality of life in patients with predominant negative symptoms of schizophrenia: A post-hoc analysis
by: Oloruntoba J. Oluboka, et al.
Published: (2025-06-01)

Negative symptoms at the prodromal stage of schizophrenia at a young age (current problems of diagnostics and treatment)
by: M. A. Omelchenko
Published: (2020-01-01)

Approval of a comprehensive psychosocial rehabilitation program for patients with negative symptoms in schizophrenia
by: Yu. A. Kushnir
Published: (2024-03-01)

A new nosology of psychosis and the pharmacological basis of affective and negative symptom dimensions in schizophrenia
by: Costa Vakalopoulos
Published: (2010-01-01)

Pharmacological Interventions for Negative Symptoms in Schizophrenia: A Systematic Review of Randomised Control Trials
by: Lorenzo Moccia, et al.
Published: (2025-02-01)

Is There a Link Between Type 2 Diabetes Mellitus and Negative Symptoms in Schizophrenia? A Scoping Review
by: István Bitter, et al.
Published: (2025-05-01)

Validation of the Romanian version of the brief negative symptom scale in a heterogeneous schizophrenia inpatient sample
by: Cosmin Ioan Moga, et al.
Published: (2025-01-01)

Dealing with schizophrenia in general practice
by: N. Khamker
Published: (2012-04-01)

Efficacy of Adjunctive Use of Repetitive Transcranial Magnetic Stimulation in Patients with Schizophrenia with Prominent Negative Symptoms: A Randomized Controlled Trial
by: Alok Kumar Shukla, et al.
Published: (2025-02-01)

Thinning of the temporal and insular cortex is associated with negative symptoms and impaired attention in Chinese chronic schizophrenia patients with deficit syndrome
by: Jin Li, et al.
Published: (2025-04-01)

Systematic review of utility values used in the pharmacoeconomic evaluations for schizophrenia: implications on cost-effectiveness results
by: Junwen Zhou, et al.
Published: (2019-01-01)

Сariprazine in the treatment of schizophrenia spectrum disorders in a hospital setting
by: O. V. Limankin, et al.
Published: (2023-10-01)

Relationship between negative symptoms, cognitive function and social function in schizophrenia: new insight from a network analysis
by: Renliang Cai, et al.
Published: (2025-06-01)

The moderating role of COMT gene rs4680 polymorphism between maladaptive metacognitive beliefs and negative symptoms in patients with schizophrenia
by: Feten Fekih-Romdhane, et al.
Published: (2024-11-01)

Interleukin-6 in schizophrenia is associated with negative symptoms, side effects of therapy and smoking: results of a pilot study
by: T. V. Zhilyaeva, et al.
Published: (2022-07-01)

Predicting models for work outcomes in patients with schizophrenia and its clinical application
by: Chika Sumiyoshi, et al.
Published: (2025-05-01)

Untangling Depression in Schizophrenia: The Role of Disorganized and Obsessive-Compulsive Symptoms and the Duration of Untreated Psychosis
by: Georgi Panov, et al.
Published: (2024-11-01)

Beyond vertebrates: Drosophila melanogaster as a model to study negative symptoms of schizophrenia
by: Maximiliano Elgueta-Reyes, et al.
Published: (2025-07-01)

Neurocognitive deficits in clinical polymorphism of schizophrenia: typology, expression and syndromal overlaps
by: A. N. Kornetov, et al.
Published: (2019-08-01)

Relationship between cognitive impairments and psychopathological symptoms in female schizophrenia subsequent to 8 weeks treatment with antipsychotic drugs
by: Shuzhan Gao, et al.
Published: (2025-03-01)

A tolerability burden index in schizophrenia: incorporating patient perspective in clinical trial adverse event reporting
by: Clément François, et al.
Published: (2017-01-01)

Accelerated iTBS with a personalised targeting method to treat negative symptoms of schizophrenia: A randomized controlled trial
by: Yunyi Han, et al.
Published: (2025-05-01)

The relationship between mindfulness, psychological flexibility, and symptom severity in persons with schizophrenia-spectrum-disorders: a cross-sectional study
by: Inge Hahne, et al.
Published: (2025-06-01)

CONTEMPORARY ISSUES AND PERSPECTIVES ON THE STUDYING OF SCHIZOPHRENIA WITH NEGATIVE SYMPTOMS LEADING
by: Ye. G. Kornetova, et al.
Published: (2014-02-01)

Pharmacogenic and neurologic components of residual condition in schizophrenia
by: V. V. Chuhunov, et al.
Published: (2022-12-01)

Comparison of beta-endorphin and CGRP levels before and after treatment for severe schizophrenia
by: Urban-Kowalczyk M, et al.
Published: (2016-04-01)

Validation of the Chinese version of Brief Assessment of Cognition in Schizophrenia
by: Wang LJ, et al.
Published: (2016-10-01)

Results of a Multicenter Clinical Study on Adaptation and Validation of the Russian Version of the Clinical Assessment Interview for Negative Symptoms (CAINS)
by: I. A. Fedotov, et al.
Published: (2024-12-01)

Humor processing and its relationship with clinical features in patients with first-episode schizophrenia
by: Yunfei Ji, et al.
Published: (2025-03-01)

A new two-hit animal model for schizophrenia research: Consequences on social behavior
by: Kristina Hakenova, et al.
Published: (2025-12-01)

COSMIN systematic review and meta-analysis of the measurement properties of the Positive and Negative Syndrome Scale (PANSS)Research in context
by: Simon Geck, et al.
Published: (2025-04-01)

Individualized transcranial temporal interference stimulation (tTIS) for cognitive impairments and negative symptoms in patients with schizophrenia: a study protocol for a randomized controlled trial
by: Shuzhe Wang, et al.
Published: (2025-07-01)

Depressive and Negative Symptoms in the Early and Established Stages of Schizophrenia: Integrating Structural Brain Alterations, Cognitive Performance, and Plasma Interleukin 6 Levels
by: Fabiana Corsi-Zuelli, et al.
Published: (2025-03-01)

A Study of The Quality of Life in Patients with Schizophrenia: A Cross-Sectional Study in A Tertiary Care Hospital, Mumbai, India
by: Prasad Tagad, et al.
Published: (2024-12-01)

The Mini-TRH Test, Dopamine Transmission, and Schizophrenia Symptoms
by: Johan Spoov
Published: (2025-06-01)